Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Tezepelumab PRO Study
Update on the tezepelumab PRO study indicating the trial has completed.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma [NA]
This clinical trial update highlights adherence to inhaled therapy as a globally overlooked issue in patients with COPD and asthma. The stud…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC) [NA]
Completed clinical trial from University Hospital, Montpellier investigating bronchial epithelium modeling in severe asthma using human indu…
-
FDA approval · 2025-09-26FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved Teva's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA), expanding the approved QVAR inhaled corti…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: PROPE Severe Asthma Study in Egypt
Clinical trial update for AstraZeneca's PROPE severe asthma study in Egypt; the trial status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics [NA]
A clinical trial evaluating unrefined salmon oil as a dietary supplement in adults with asthma has completed.
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
Clinical trial investigating Type 2 Innate Lymphoid Cells in severe pediatric asthma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation [Phase 1]
Phase 1 pilot study to identify mediators and inflammatory cell surface receptors involved in allergic airway inflammation in asthma; status…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Daily Vitamin D for Sickle-cell Respiratory Complications [Phase 2]
Phase 2 trial evaluating daily vitamin D for sickle cell–related respiratory complications has completed and posted results.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
This is an observational study (CHRONICLE) in the United States examining characteristics, treatment, and outcomes of people with severe ast…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
A longitudinal phenotyping and endotyping study in adults with asthma across severity levels. The sponsor is Hvivo and the study is currentl…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study). [NA]
A study analyzing a joint pulmonologist and ENT consultation pathway for asthma with chronic rhinosinusitis with nasal polyps, assessing eff…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study [Phase 2]
This Phase 2 clinical trial update evaluates the long-term safety and efficacy of subcutaneous amlitelimab in adults with moderate-to-severe…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Impact of Sleep Duration on Immune Balance in Urban Children With Asthma [NA]
This clinical trial is studying how sleep duration impacts immune balance in urban children with asthma and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care [NA]
This clinical trial evaluates the impact of a care pathway on pediatric asthma management across primary and hospital care and is currently …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Using Technology-Assisted Stepped Care Intervention to Improve Adherence in Adolescents With Asthma [NA]
This clinical trial reports the completion and posted results of a technology-assisted stepped-care intervention aimed at improving adherenc…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
REACT, a trial to identify patients with severe uncontrolled asthma, has been terminated.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: SMART Implementation-Effectiveness Trial 2 [NA]
Clinical trial update for the SMART Implementation-Effectiveness Trial 2 in pediatric asthma, currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: SMART Implementation-Effectiveness Trial 1 [NA]
The SMART Implementation-Effectiveness Trial 1 for asthma in children is currently recruiting, sponsored by Children's Hospital of Philadelp…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for asthma patients who a…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating symptom-driven inhaled corticosteroid/long-acting beta-agonist thera…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases [Phase 4]
Phase 4 trial evaluating mepolizumab for chronic cough associated with eosinophilic airway diseases has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease [Phase 2]
Phase 2 trial evaluating the benefits of IL-4 receptor alpha inhibition for aspirin-exacerbated respiratory disease, including asthma and na…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM) [NA]
Clinical trial REverse Lung Airway and Vascular Remodeling in Asthma Remission (ReNORM) is not yet recruiting and is studying asthma with eo…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: The Effect of Thyme Oil in Asthmatic Patients [NA]
Clinical trial update indicating completion of a study evaluating thyme oil in asthmatic patients.